publication . Article . 2013

Prevalence and Associated Factors in Self-Monitoring of Blood Glucose in Noninsulin-treated Type 2 Diabetes Patients in the Valencia Community, Spain

Amparo Barreda-Aznar; Pedro Cervera-Casino; Diego Cano-Blanquer; Mónica Mateu-García; Salvador Peiró-Moreno;
Open Access
  • Published: 01 Apr 2013 Journal: Revista Española de Salud Pública, volume 87, pages 149-163 (issn: 1135-5727, Copyright policy)
  • Publisher: Instituto de Salud Carlos III/BNCS/SciELO Espana
Abstract
Fundamentos: La utilidad de la automonitorización de la glucemia (AMGS) en pacientes con diabetes tipo 2 (DM2) no tratados con insulina (NTI) es objeto de controversia. Los objetivos de este trabajo son describir la prevalencia de AMGS en sujetos con DM2 NTI en la Comunidad Valenciana y analizar los factores asociados a su a su uso. Método: Estudio transversal en 83 consultas de atención primaria mediante revisión de la historia clínica electrónica y entrevista a 573 sujetos con DM2-NTI. Se analizó la asociación entre la indicación de AMGS y las características del paciente, médico y organizativas. Resultados: 289 (50,4%) de los pacientes con DM2-NTI utilizaban ...
Subjects
free text keywords: General Medicine, Diabetes Mellitus tipo 2, Automonitorización de glucosa en sangre, Utilización de medicamentos, Antidiabéticos orales, Estudios transversales, Diabetes Mellitus, Type 2, Blood Glucose Self-Monitoring, Drug utilization, Hypoglycemic Agents, Cross-Sectional Studies, Spain, Primary care, Patient interview, Obesity, medicine.disease, medicine, Type 2 diabetes, Health care, business.industry, business, Family medicine, medicine.medical_specialty, Medical record, Self-monitoring, Professional practice
30 references, page 1 of 2

11. Coster S, Gulliford MC, Seed PT, Powrie JK, Swaminathan R. Selfmonitoring in type 2 diabetes mellitus: A meta-analysis. Diabet Med. 2000; 17:755-761.

12. Towfigh A, Romanova M, Weinreb JE, Munjas B, Suttorp MJ, Zhou A, et al. Self-monitoring of blood glucose levels in patients with type 2 diabetes mellitus not taking insulin: a meta-analysis. Am J Manag Care. 2008;14:468-75.

13. Davidson MB. Evaluation of self monitoring of blood glucose in non-insulin-treated diabetic patients by randomized controlled trials: little bang for the buck. Rev Recent Clin Trials. 2010;5:138-42.

14. Clar C, Barnard K, Cummins E, Royle P, Waugh N; Aberdeen Health Technology Assessment Group. Selfmonitoring of blood glucose in type 2 diabetes: systematic review. Health Technol Assess. 2010;14:1-140.

15. Welschen LM, Bloemendal E, Nijpels G, Dekker JM, Heine RJ, Stalman WA, et al. Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin. Cochrane Database Syst Rev. 2005 Apr 18;(2):CD005060. [OpenAIRE]

16. Clua Espuny JL, Puig Junoy J, Queralt Tomás ML, Palau Galindo A. Análisis coste-efectividad de la automonitorizacion de la glucosa sanguinea en diabeticos tipo 2. Gac Sanit. 2000;14:442-8. [OpenAIRE]

17. Simon J, Gray A, Clarke P, Wade A, Neil A, Farmer A; Diabetes Glycaemic Education and Monitoring Trial Group. Cost effectiveness of self monitoring of blood glucose in patients with non-insulin treated type 2 diabetes: economic evaluation of data from the DiGEM trial. BMJ. 2008;336:1177-80.

23. Gomes T, Juurlink DN, Shah BR, Paterson JM, Mamdani MM. Blood glucose test strips: options to reduce usage. CMAJ. 2010;182:35-8.

24. Belsey JD, Pittard JB, Rao S, Urdahl H, Jameson K, Dixon T. Self blood glucosemonitoring in type 2 diabetes. A financial impact analysis based on UK primary care. Int J Clin Pract. 2009;63:439-48.

25. Gulliford M, Latinovic R. Variations in glucose self-monitoring during oral hypoglycaemic therapy in primary care. Diabet Med. 2004;21:685-90. [OpenAIRE]

26. Ricordeau P, Weill A, Vallier N, Bourrel R, Schwartz D, Guilhot J, et al. The prevalence and cost of diabetes in metropolitan France: what trends between 1998 and 2000?*. Diabetes Metab. 2003;29:497-504.

27. Centers for Disease Control and Prevention (CDC). Self-monitoring of blood glucose among adults with diabetes--United States, 1997-2006. MMWR Morb Mortal Wkly Rep. 2007;56:1133-7.

28. Patel H, Srishanmuganathan J, Car J, Majeed A. Trends in the prescription and cost of diabetic medications and monitoring equipment in England 1991- 2004. J Public Health (Oxf). 2007;29:48-52.

29. Rathmann W, Haastert B, Icks A, Giani G. Trends in outpatient prescription drug costs in diabetic patients in Germany, 1994-2004. Diabetes Care. 2007;30:848-53.

30. Neutel CI, Campbell NR, Morrison HI. Trends in diabetes treatment in Canadians, 1994-2004. Chronic Dis Can. 2010;30:107-11.

30 references, page 1 of 2
Any information missing or wrong?Report an Issue